Does FOSFOMYCIN TROMETHAMINE Cause Bladder transitional cell carcinoma? 21 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 21 reports of Bladder transitional cell carcinoma have been filed in association with FOSFOMYCIN TROMETHAMINE (FOSFOMYCIN TROMETHAMINE). This represents 2.7% of all adverse event reports for FOSFOMYCIN TROMETHAMINE.
21
Reports of Bladder transitional cell carcinoma with FOSFOMYCIN TROMETHAMINE
2.7%
of all FOSFOMYCIN TROMETHAMINE reports
0
Deaths
21
Hospitalizations
How Dangerous Is Bladder transitional cell carcinoma From FOSFOMYCIN TROMETHAMINE?
Of the 21 reports, 21 (100.0%) required hospitalization.
Is Bladder transitional cell carcinoma Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for FOSFOMYCIN TROMETHAMINE. However, 21 reports have been filed with the FAERS database.
What Other Side Effects Does FOSFOMYCIN TROMETHAMINE Cause?
Off label use (94)
Diarrhoea (86)
Nausea (61)
Drug ineffective (60)
Product use issue (57)
Vomiting (54)
Dizziness (52)
Dyspnoea (48)
Headache (45)
Fatigue (44)
What Other Drugs Cause Bladder transitional cell carcinoma?
PIOGLITAZONE (398)
ADALIMUMAB (96)
METHOTREXATE (95)
RITUXIMAB (74)
TOCILIZUMAB (68)
INFLIXIMAB (63)
SULFASALAZINE (55)
HYDROXYCHLOROQUINE (50)
PREDNISONE (48)
LENALIDOMIDE (42)
Which FOSFOMYCIN TROMETHAMINE Alternatives Have Lower Bladder transitional cell carcinoma Risk?
FOSFOMYCIN TROMETHAMINE vs FOSINOPRIL
FOSFOMYCIN TROMETHAMINE vs FOSPHENYTOIN
FOSFOMYCIN TROMETHAMINE vs FOSTAMATINIB
FOSFOMYCIN TROMETHAMINE vs FOSTEMSAVIR TROMETHAMINE
FOSFOMYCIN TROMETHAMINE vs FOTEMUSTINE